Drug access. Unclogging the pipeline.

Abstract

For years, the FDA's ponderous drug approval process has been the target of complaints and protests. But the logjam is finally beginning to give way, and the regulatory system is responding to patients' desires and needs. Although AIDS is the unquestioned catalyst for change, observers say patients with other serious diseases will benefit as well.